Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: TF for the Prediction of Visual Field Progression [NA]
The clinical trial NCT03047239 evaluating TF for predicting visual field progression in open-angle glaucoma has been withdrawn.
-
EMA withdrawal · 2024-12-17EMA Application withdrawn: Durysta (bimatoprost) — AbbVie Deutschland GmbH & Co. KG
The EMA has withdrawn the marketing authorization application for Durysta (bimatoprost) submitted by AbbVie Deutschland GmbH & Co. KG for op…
-
CLINICAL_TRIALS withdrawal · 2024-05-20Clinical Trial Update: Effect of Negative Pressure on Pattern Electroretinography Readings [NA]
A clinical trial examining the effect of negative pressure on pattern electroretinography readings in glaucoma-related conditions has been w…
-
CLINICAL_TRIALS withdrawal · 2022-04-07Clinical Trial Update: Pilocarpine After Combined Cataract/Trabectome Surgery [Phase 3]
Phase 3 trial of pilocarpine after combined cataract/trabectome surgery was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-11-19Clinical Trial Update: A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing SDP-133 (Sun Pharma) daily with Lumigan in open-angle glaucoma or ocular hypertension was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-06-21Clinical Trial Update: African Glaucoma Laser Trial [Phase 4]
A Phase 4 clinical trial on open-angle glaucoma conducted in Africa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-02Clinical Trial Update: Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device [Phase 3]
Phase 3 trial evaluating safety and efficacy of Xalatan delivered by a conventional dropper bottle versus a delivery device was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-08Clinical Trial Update: iDropper Usability in Glaucoma [Phase 1]
A Phase 1 usability trial of the iDropper device for open-angle glaucoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-09Clinical Trial Update: The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
A clinical trial evaluating the effect of omega-3 fatty acid supplementation on intraocular pressure and ocular surface in open-angle glauco…
-
CLINICAL_TRIALS withdrawal · 2015-03-10Clinical Trial Update: Choroidal Blood Flow Response to Hand-grip Test in Progressive Glaucoma
A clinical trial on choroidal blood flow response to hand-grip exercise in progressive glaucoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH [Phase 3]
A Phase 3 trial comparing latanoprost/brinzolamide to latanoprost alone in open-angle glaucoma or ocular hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-11-21Clinical Trial Update: Progressive Open Angle Glaucoma (OAG) and Ocular Blood Flow [NA]
A clinical trial investigating progressive open-angle glaucoma and ocular blood flow has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-13Clinical Trial Update: IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy [NA]
A clinical trial exploring intraocular pressure fluctuations in primary open-angle glaucoma patients undergoing deep sclerectomy has been wi…
-
CLINICAL_TRIALS withdrawal · 2013-11-26Clinical Trial Update: Prevalence of Dyschromatopsia in Glaucoma Patients
A trial investigating the prevalence of dyschromatopsia in open-angle glaucoma has been withdrawn. The study status indicates it was cancele…
-
CLINICAL_TRIALS withdrawal · 2012-10-25Clinical Trial Update: The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients
The clinical trial NCT00465348 investigating the antioxidant effect of routine vascular therapy in normal tension glaucoma has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2012-10-18Clinical Trial Update: Travacom Post Marketing Surveillance Study [Phase 4]
A Phase 4 post-marketing surveillance study of Travacom for open-angle glaucoma and ocular hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-06Clinical Trial Update: Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops
A clinical trial investigating the effects of Forskolin on intraocular pressure in patients with primary open-angle glaucoma under beta-bloc…
-
CLINICAL_TRIALS withdrawal · 2012-06-06Clinical Trial Update: Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy
A clinical trial evaluating forskolin for lowering intraocular pressure in patients with primary open-angle glaucoma on maximum tolerated me…
-
CLINICAL_TRIALS withdrawal · 2012-05-30Clinical Trial Update: A Multi-Dose Study With a Treatment for Open-Angle Glaucoma [Phase 2, Phase 3]
A multi-dose Phase 2/3 clinical trial for a treatment of open-angle glaucoma has been withdrawn, representing a status change for the study.…
-
CLINICAL_TRIALS withdrawal · 2012-03-16Clinical Trial Update: The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) [NA]
This clinical trial update indicates the study comparing Cosopt (dorzolamide/timolol) and Xalacom (latanoprost/timolol) in open-angle glauco…
-
CLINICAL_TRIALS withdrawal · 2012-02-10Clinical Trial Update: Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% [Phase 3]
A Phase 3 study comparing TRAVATAN to Travoprost Ophthalmic Solution (0.004%) for open-angle glaucoma and ocular hypertension has been withd…
-
CLINICAL_TRIALS withdrawal · 2012-01-18Clinical Trial Update: Safety and Efficacy Study of DuoTrav APS Versus DuoTrav [Phase 3]
A Phase 3 safety and efficacy trial comparing DuoTrav APS to DuoTrav was withdrawn, involving open-angle glaucoma and ocular hypertension.